Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vallance

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|January 15, 1998
Drug therapy for coronary heart disease: the Sheffield tableP Vallance, J Martin
Gut|May 13, 1998
Nitric oxide as an antimicrobial agent: does NO always mean NO? [ comment]P Vallance, I Charles
Cardiovascular Research|February 26, 2000
Biological significance of endogenous methylarginines that inhibit nitric oxide synthasesJ Leiper, P Vallance
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Evidence for functional responses to sensory nerve stimulation of rat small mesenteric veinsA Ahluwalia, P Vallance
British Journal of Pharmacology|December 25, 2008
Endothelium-derived relaxing factor is an endogenous vasodilator in manJ Collier, P Vallance
Lancet (London, England)|October 1, 1994
Plasma nitrite as a marker of nitric oxide productionN Benjamin, P Vallance
Critical Care Medicine|March 1, 1995
Ketoconazole and nitric oxideR Bogle, P Vallance
Trends in Pharmacological Sciences|July 1, 1993
Investigation of vascular mechanisms: bridging the gap between basic research and clinical trialsJ Collier, P Vallance
International Journal of Experimental Pathology|January 13, 2000
Endothelial nitric oxide in humans in health and diseaseP Vallance, A Hingorani
Heart (British Cardiac Society)|February 17, 2001
Endothelial function and nitric oxide: clinical relevanceP Vallance, N Chan
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|January 15, 1998
Drug therapy for coronary heart disease: the Sheffield tableP Vallance, J Martin
Gut|May 13, 1998
Nitric oxide as an antimicrobial agent: does NO always mean NO? [ comment]P Vallance, I Charles
Cardiovascular Research|February 26, 2000
Biological significance of endogenous methylarginines that inhibit nitric oxide synthasesJ Leiper, P Vallance
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Evidence for functional responses to sensory nerve stimulation of rat small mesenteric veinsA Ahluwalia, P Vallance
British Journal of Pharmacology|December 25, 2008
Endothelium-derived relaxing factor is an endogenous vasodilator in manJ Collier, P Vallance
Lancet (London, England)|October 1, 1994
Plasma nitrite as a marker of nitric oxide productionN Benjamin, P Vallance
Critical Care Medicine|March 1, 1995
Ketoconazole and nitric oxideR Bogle, P Vallance
Trends in Pharmacological Sciences|July 1, 1993
Investigation of vascular mechanisms: bridging the gap between basic research and clinical trialsJ Collier, P Vallance
International Journal of Experimental Pathology|January 13, 2000
Endothelial nitric oxide in humans in health and diseaseP Vallance, A Hingorani
Heart (British Cardiac Society)|February 17, 2001
Endothelial function and nitric oxide: clinical relevanceP Vallance, N Chan
Pageof 16